99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.
|Original language||English (US)|
|Number of pages||7|
|State||Published - Nov 1 2003|
ASJC Scopus subject areas
- Drug Discovery